TITLE

Alcoholic Liver Disease-Related Mortality in the United States: 1980–2003

AUTHOR(S)
Paula, Helga; Asrani, Sumeet K.; Boetticher, Nicholas C.; Pedersen, Rachel; Shah, Vijay H.; Kim, W. Ray
PUB. DATE
August 2010
SOURCE
American Journal of Gastroenterology;Aug2010, Vol. 105 Issue 8, p1782
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVES:Data on temporal changes in alcoholic liver disease (ALD)-related mortality in the United States are lacking. This longitudinal assessment is important, given the divergent data on trends in worldwide ALD-related mortality, concerns for underestimation of mortality attributed to ALD in previous investigations, and shifting attention to hepatitis C virus (HCV)-related mortality.METHODS:We analyzed mortality data compiled in the multiple cause-of-death public-use data file from the National Vital Statistics System from 1980 to 2003 using categorization by both International Classification of Diseases (ICD)-9 and ICD-10 systems. The main outcome measure was age- and sex-adjusted death rates attributable to ALD, HCV, or both (ALD/HCV) listed as immediate or underlying cause of death.RESULTS:A total of 287,365 deaths were observed over the 24-year period. Age- and sex- adjusted incidence rates of ALD-related deaths decreased from 6.9/100,000 persons in 1980 to 4.4/100,000 persons by 2003. After introduction of HCV diagnostic testing, HCV-related liver mortality increased to 2.9/100,000 persons by 2003. Death rates for subjects with concomitant ALD/HCV rose to 0.2/100,000 persons by 1999 and then remained unchanged through 2003. Age-specific mortality related to ALD was highest in the ages of 45–64 years. Between 1980 and 2003, the age- and sex-adjusted ALD-related mortality (per 100,000 persons) decreased from 6.3 to 4.5 among Caucasians, 11.6 to 4.1 among African Americans, and 8.0 to 3.7 among the “other” race group.CONCLUSIONS:Despite a decline in ALD-related mortality, the proportion of alcohol-related liver deaths is still considerably large and comparable in scope to that of HCV.
ACCESSION #
52703063

 

Related Articles

  • Liver Transplantation for Alcoholic Liver Disease with or Without Hepatitis C. Goldar-Najafi, Atoussa; Gordon, Fredric D.; Lewis, W. David; Pomfret, Elizabeth; Pomposelli, James J.; Jenkins, Roger L.; Khettry, Urmila // International Journal of Surgical Pathology;Apr2002, Vol. 10 Issue 2, p115 

    Examines the impact of concomitant hepatitis C virus (HCV) on alcoholic liver disease patients undergoing liver transplantation (LT). Number of patients with cirrhosis at LT; List of native liver features; Recurrence of post-LT HCV.

  • Hepatitis C virus (HCV):prevalence in a gynecological urgent care clinic population. Adusumalli, J.; Bonney, E. A.; Odenat, L.; Jamieson, D. J. // Infectious Diseases in Obstetrics & Gynecology;2004, Vol. 12 Issue 1, p9 

    Objective: To determine the prevalence of hepatitis C virus (HCV) among women seeking urgent gynecological care. Methods: Women were asked to complete a short self-assessment screening of HCV risk. Those answering yes to any of the screening questions were offered HCV testing and were asked to...

  • What do abnormal liver function test results really mean? Kaplan, Marshall M.; Keeffe, Emmet B. // Patient Care;May2003, Vol. 37 Issue 5, p35 

    Offers several facts about diagnosing hepatocellular or cholestatic liver diseases. Background on aminotransferases; Information on alcoholic liver disease; Initial test for diagnosis of hepatitis C virus infection; Explanation on autoimmune hepatitis.

  • Alcoholic liver disease and hepatitis C: A frequently underestimated combination. Mueller, Sebastian; Millonig, Gunda; Seitz, Helmut K.; Bock, Thomas; Mutchnick, Milton G.; Mencin, Ali // World Journal of Gastroenterology;7/28/2009, Vol. 15 Issue 28, p3462 

    Alcoholic liver disease (ALD) and hepatitis C virus (HCV) infection represent, either alone or in combination, more than two thirds of all patients with liver disease in the Western world. This review discusses the epidemiology and combined impact of ALD and HCV on the progression of liver...

  • Hepatocellular Carcinoma Prevalence and Mortality in a Male State Prison Population. Baillargeon, Jacques; Snyder, Ned; Soloway, Roger D.; Paar, David; Baillargeon, Gwen; Spaulding, Anne C.; Pollock, Brad H.; Arcari, Christine M.; Williams, Brie A.; Raimer, Ben G. // Public Health Reports;Jan/Feb2009, Vol. 124 Issue 1, p120 

    Objectives. The incidence of hepatocellular carcinoma (HCC) in the United States has increased dramatically over the last two decades, largely because of an increase in the number of people with advanced hepatitis C virus (HCV) infection. U.S. prisoners are at high risk for HCC, given their...

  • Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Roulot, Dominique; Costes, Jean-Luc; Buyck, Jean-François; Warzocha, Ursula; Gambier, Nicolas; Czernichow, Sébastien; Le Clesiau, Hervé; Beaugrand, Michel // Gut;Jul2011, Vol. 60 Issue 7, p977 

    Background Liver stiffness measurement (LSM) has been used to measure fibrosis in patients with various types of chronic liver diseases. However, its usefulness as a screening procedure in apparently healthy people had not been evaluated to date. Methods 1358 subjects >45 years old from a...

  • Making the best of a bad situation: early chronic nosocomial HCV infection. Santos, Carmi; Herrine, Steven K. // Digestive Diseases & Sciences;Jun2010, Vol. 55 Issue 6, p1509 

    An introduction to the journal is presented in which the editor discusses a study related to the acute nosocomial hepatitis C virus (HCV) infection and its treatment.

  • HCV, waist circumference linked to greater liver stiffness.  // Infectious Disease News;Oct2013, Vol. 26 Issue 10, p36 

    The article discusses a study published in a 2013 issue of "The Journal of Infectious Diseases" that examined the association between hepatitis C virus (HCV) and liver stiffness.

  • A genotypic association implicates myeloperoxidase in the progression of hepatic fibrosis in chronic hepatitis C virus infection. Reynolds, W.F.; Patel, K.; Pianko, S.; Blatt, L.M.; Nicholas, J.J.; McHutchison, J.G. // Genes & Immunity;Sep2002, Vol. 3 Issue 6, p345 

    The hepatitis C virus (HCV) is a major cause of fiver disease and the complications of cirrhosis. Liver biopsies, performed prior to the development of liver cirrhosis, characteristically show an inflammatory cell infiltrate with varying degrees of fibrosis. Precisely how HCV infection induces...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics